Shouyao Liu | Analysis | Best Researcher Award

Posted on by ScienceFather

Shouyao Liu | Analysis | Best Researcher Award

Prof.Dr. Liu Shouyao , Traditional Chinese Medicine Surgery , China.

👨‍⚕️Liu Shouyao,is an Associate Chief Physician and Deputy Director of the Traditional Chinese Medicine Surgery Department at China-Japan Friendship Hospital. He also serves as the Deputy Director of the Medical Department at the National Center for Integrated Traditional Chinese and Western Medicine Affairs Committee. A dedicated expert in wound healing, he specializes in diabetic foot treatment, venous ulcers, and bedsores using a combination of Traditional Chinese Medicine (TCM) and modern medical techniques. A CPC member, he actively contributes to medical research, education, and committee leadership in integrated medicine. 🇨🇳✨

Publication Profile

Orcid
Scopus

Education & Work Experience 🎓💼

✅ Education 📚
  • 🎓 Master’s Degree in Medicine – Beijing University of Chinese Medicine, June 2012
  • 🎓 Doctorate in Medicine – Beijing University of Chinese Medicine, June 2015
✅ Work Experience 🏥
  • 🏥 Since August 2015 – China-Japan Friendship Hospital, Department of Traditional Chinese Medicine Surgery

Suitability Summary

Dr. Shouyao Liu, a distinguished recipient of the Best Researcher Award, is a Doctor of Medicine, Associate Chief Physician, and Deputy Director of the Traditional Chinese Medicine Surgery Department at China-Japan Friendship Hospital. He is widely recognized for his pioneering research in chronic wound treatment, integrating Traditional Chinese Medicine (TCM) and Western medicine to develop innovative and effective healing techniques. His work has significantly improved diabetic foot care, venous ulcers, pressure sores, radiation ulcers, and chronic mastitis treatment.

Professional Development 🌱🏥

🩺 Dr. Liu specializes in treating chronic wounds using an integrative approach combining traditional Chinese and Western medicine. His expertise spans diabetic foot, pressure sores, radiation ulcers, and mastitis. He employs surgical debridement, ultrasonic therapy, negative pressure wound treatment, and TCM-based methods such as herbal preparations and moist healing techniques. 🌿 His research focuses on early prevention, treatment, and rehabilitation of diabetic foot, reducing complications and improving limb function. 🚑 His dedication to advancing wound healing strategies has made him a key figure in the field of integrative medicine. 📚🔬

Research Focus 🔬📖

🔬 Dr. Liu’s primary research area is the role of TCM external treatment technology in chronic wound inflammation regulation. His work explores how herbal medicine, moist healing, and surgical techniques can accelerate wound healing, reduce infections, and improve patient recovery. He has contributed significantly to the early intervention and management of diabetic foot using integrative techniques. His research also examines novel Chinese herbal formulations to enhance tissue regeneration. 🌱 By integrating ancient wisdom with modern innovations, Dr. Liu aims to develop effective treatments for non-healing wounds, benefiting patients worldwide. 🌏🩹

Awards & Honors 🏅🎖

✅ China-Japan Friendship Hospital “Elite Program” Backbone Talent
✅ 2023 High-Level Clinical Research Special Fund Project Director
✅ Beijing Traditional Chinese Medicine Science and Technology Development Fund Awardee
✅ China-Japan Friendship Hospital Youth Fund Recipient
✅ Beijing University of Chinese Medicine Education Research Grant Recipient
✅ Beijing Municipal Science and Technology Commission Expert Reviewer

Publication Top Notes

“Effect of surface adhesion characteristics on stick-slip mechanism of flexible film/substrate bilayer structure: Multiscale insight” 🏛️ Tribology International, 2025 📅 

Meng Qiu | Analysis Awards | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Meng Qiu | Analysis Awards | Best Researcher Award

Assoc Prof Dr. Meng Qiu, Ocean University of China, China

Associate Professor and Ph.D. Supervisor at the College of Chemistry and Chemical Engineering, Ocean University of China. His research focuses on nanobiomedicine and optoelectronics, including the preparation of low-dimensional nanomaterials and their biomedical applications. With over 80 publications and an H-index of 40, Dr. Qiu has received multiple awards, including the Shenzhen Natural Science Award and recognition as a top global scientist. He actively contributes as an editorial board member and guest editor for several journals.

Publication profile

Google Scholar

Education Background

Assoc. Prof. Dr. Meng Qiu holds a diverse educational background. He earned his Ph.D. in Physical Chemistry (2009-2013) from the State Key Laboratory of Molecular Reaction Dynamics, Institute of Chemistry, Chinese Academy of Sciences. He completed his M.S. in Applied Chemistry (2006-2009) at the Key Laboratory of Marine Chemistry Theory and Technology, Ocean University of China, following a B.S. in Applied Chemistry (2002-2006) at Qilu University of Technology. Dr. Qiu’s postdoctoral research includes positions at Shenzhen University (2016-2019) and the Qingdao Institute of Bioenergy and Bioprocess Technology (2014-2016) and served as a Research Professor at Korea University (2017-2018). 🌊🔬

 

Awards and Recognitions

Assoc. Prof. Dr. Meng Qiu has been honored with prestigious awards for his significant contributions to the field of nanobiomedicine. In 2023, he received the Second Prize of the Qingdao Natural Science Award for his groundbreaking work titled “Controllable Preparation and Photodynamic Therapy Mechanism of Two-Dimensional Pnictogens.” This research highlighted his innovative approach to preparing nanomaterials with potential therapeutic applications. Additionally, he was awarded the First Prize of the Shenzhen Natural Science Award in 2023 for his work on “Large-Scale Controllable Preparation of Two-Dimensional Phosphorene and Its Biomedical Applications.” This recognition underscores his excellence in developing novel nanomaterials that can significantly impact biomedical fields. Dr. Qiu’s achievements not only showcase his research expertise but also reflect his commitment to advancing science for societal benefit. 🌟🔬🏅

 

Research Interests

Assoc. Prof. Dr. Meng Qiu’s research focuses on the design, preparation, and functionalization of novel nanomaterials. He explores the optoelectronic properties of these materials and their interactions at the nanobiological interface, aiming to bridge the gap between nanotechnology and biology. His work also delves into the development of intelligent nanodiagnostic and therapeutic platforms and innovative biosensors, which have significant applications in medical diagnostics and treatment. Through his cutting-edge research, Dr. Qiu contributes to advancing the field of nanobiomedicine, enhancing our understanding of how nanomaterials can be utilized for health innovations. 🌍🧪

 

Publication Top Notes

  • “Novel concept of the smart NIR-light–controlled drug release of black phosphorus nanostructure for cancer therapy” – M Qiu et al. | Cited by: 755 | Year: 2018 📄✨
  • “Molecular dynamics and density functional theory study on relationship between structure of imidazoline derivatives and inhibition performance” – S Xia, M Qiu et al. | Cited by: 440 | Year: 2008 🔬🔍
  • “Omnipotent phosphorene: a next-generation, two-dimensional nanoplatform for multidisciplinary biomedical applications” – M Qiu et al. | Cited by: 403 | Year: 2018 🧬🌐
  • “Biocompatible and biodegradable inorganic nanostructures for nanomedicine: silicon and black phosphorus” – M Qiu et al. | Cited by: 266 | Year: 2019 💊🌱
  • “Conceptually novel black phosphorus/cellulose hydrogels as promising photothermal agents for effective cancer therapy” – C Xing, S Chen, M Qiu et al. | Cited by: 259 | Year: 2018 🧪🔥
  • “Electrochemical behavior of Q235 steel in saltwater saturated with carbon dioxide based on new imidazoline derivative inhibitor” – FG Liu, M Du, M Qiu | Cited by: 258 | Year: 2009 ⚙️🌊
  • “The rise of 2D photothermal materials beyond graphene for clean water production” – Z Xie, Y Duo, M Qiu et al. | Cited by: 243 | Year: 2020 💧📈
  • “Current progress in black phosphorus materials and their applications in electrochemical energy storage” – M Qiu et al. | Cited by: 239 | Year: 2017 🔋🔋
  • “Graphene oxide/black phosphorus nanoflake aerogels with robust thermo-stability and significantly enhanced photothermal properties in air” – C Xing, M Qiu et al. | Cited by: 225 | Year: 2017 ☀️🌡️
  • “Black phosphorus-based photothermal therapy with aCD47-mediated immune checkpoint blockade for enhanced cancer immunotherapy” – Z Xie, M Qiu et al. | Cited by: 177 | Year: 2020 🦠🛡️

Conclusion

Dr. Meng Qiu’s extensive publication record, significant impact in his field, recognition through awards, and leadership roles in academic circles make him a highly suitable candidate for the Research for Best Researcher Award. His innovative research and contributions to nanobiomedicine and optoelectronics position him as a leader in his field, deserving of this recognition.

 

 

Dr. Naveen Dubey | Analytical Award | Best Researcher Award

Posted on by ScienceFather

Dr. Naveen Dubey | Analytical Award | Best Researcher Award 

Dr. Naveen Dubey , Mediclin Clinical Services , India

Naveen Kumar Dubey is a distinguished pharmaceutical expert with over 22 years of experience in analytical development and bioanalytical research. Currently serving as the Vice President of CRO Operations at Mediclin Clinical Services Pvt. Ltd., Naveen oversees bioanalytical CROs and ensures adherence to GLP and GCP standards. His role involves managing operational budgets, implementing strategic plans, and coordinating with various stakeholders.

Profile :

Google Scholar

Education:

  • Ph.D. in Chemistry
    IGNOU, Delhi, India (2017-2020) 📚
  • M.Tech. in Modern Methods of Chemical Analysis
    IIT Delhi, India (Jul 1999 – Dec 2000) 🎓
  • M.Sc. in Organic Chemistry
    Delhi University, India (1997-1999) 🧪

Work Experience:

  • Vice President-CRO Operation
    Mediclin Clinical Services Pvt. Ltd., Lucknow, India (Jan 2023 – Present)
    🚀 Oversaw bioanalytical CROs, managed operational budget (~700,000 USD), and coordinated study deliverables.
  • Associate Director (HOD) – Bioanalytical Operation
    Jubilant Generics Ltd., Noida, India (Jun 2020 – Jan 2023)
    🧬 Managed bioanalytical operations, led a team, ensured GCLP & GDP compliance, and handled regulatory inspections.
  • Research Scientist – Clinical Pharmacology and Pharmacokinetics
    Ranbaxy Research Laboratories, Gurgaon, Haryana, India (Oct 2002 – Jan 2006)
    🔬 Conducted bioequivalence studies, developed and validated methods for drug estimation, and ensured compliance with USFDA norms.
  • Research Officer – Analytical Division
    Sun Pharma Advanced Research Centre, Akota, Baroda, Gujarat, India (Feb 2001 – Oct 2002)
    🧪 Started professional career in pharmaceutical R&D, handled various drug analyses, and managed calibration of HPLC instruments.

 

Publication top Notes :

Improved simultaneous quantitation of candesartan and hydrochlorthiazide in human plasma by UPLC–MS/MS and its application in bioequivalence studies

Citation – 29

Bioanalytical method development and validation of alimemazine in human plasma by LC-MS/MS and its application in bioequivalence studies

Citation – 10

Interconversion from N‐Desmethyl Clomipramine to Clomipramine and its impact on a bioequivalence study

Citation – 7

Ultra-performance liquid chromatography electrospray ionization–tandem mass spectrometry method for the simultaneous determination of itraconazole and hydroxy itraconazole in …

Citation – 7

A liquid chromatography tandem mass spectrometry based regulatory compliant method for the determination of tenofovir in human serum

Citation – 4